[Malaria therapy; ups and downs, how much longer?].

  • Piet A. Kager
  • Published 1997 in Nederlands tijdschrift voor geneeskunde

Abstract

The natural products quinine and artemisinine have been effective antimalarials for centuries. Most synthetic antimalarials were developed because of pressure of war; against all some degree of resistance has developed. The newer drugs are too expensive for large-scale use. Development of new antimalarials is financially too risky for the pharmaceutical industry. Co-operation among industries, research institutes, governments and international organizations is coming off the ground. Dutch researchers should contribute to international malaria research for humanitarian reasons and out of self-interest, for the benefit of public health.

Cite this paper

@article{Kager1997MalariaTU, title={[Malaria therapy; ups and downs, how much longer?].}, author={Piet A. Kager}, journal={Nederlands tijdschrift voor geneeskunde}, year={1997}, volume={141 37}, pages={1764-6} }